vimarsana.com
Home
Live Updates
Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial : vimarsana.com
Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial
Findings from a novel study supports the JAK inhibitor tofacitinib as a potential first-line therapy for ASUC.
Related Keywords
India ,
Ravi Shah ,
,
Tofacitinib ,
Ulcerative Colitis ,
Uc ,
Asuc ,
Tacos ,
Trial ,
Jak ,
Inhibitor ,
Data ,
Research ,
Cleveland Clinic ,
vimarsana.com © 2020. All Rights Reserved.